Global Vaccine Contract Manufacturing Market Research Report 2026(Status and Outlook)

February 2026 | 134 pages | ID: GE2DD67033D1EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Vaccine Contract Manufacturing market size was estimated at USD 1966.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Vaccine Contract Manufacturing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Vaccine Contract Manufacturing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccine Contract Manufacturing market.

Global Vaccine Contract Manufacturing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics

Market Segmentation (by Type)

Fill-Finish
Bulk Product

Market Segmentation (by Application)

Pharmaceutical Companies
Biotech Companies
Others

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaccine Contract Manufacturing Market
Overview of the regional outlook of the Vaccine Contract Manufacturing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Vaccine Contract Manufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Vaccine Contract Manufacturing
1.2 Key Market Segments
  1.2.1 Vaccine Contract Manufacturing Segment by Type
  1.2.2 Vaccine Contract Manufacturing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 VACCINE CONTRACT MANUFACTURING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Vaccine Contract Manufacturing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Vaccine Contract Manufacturing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 VACCINE CONTRACT MANUFACTURING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Vaccine Contract Manufacturing Product Life Cycle
3.3 Global Vaccine Contract Manufacturing Sales by Manufacturers (2020-2025)
3.4 Global Vaccine Contract Manufacturing Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccine Contract Manufacturing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Vaccine Contract Manufacturing Market Competitive Situation and Trends
  3.8.1 Vaccine Contract Manufacturing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Vaccine Contract Manufacturing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 VACCINE CONTRACT MANUFACTURING INDUSTRY CHAIN ANALYSIS

4.1 Vaccine Contract Manufacturing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF VACCINE CONTRACT MANUFACTURING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Vaccine Contract Manufacturing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Vaccine Contract Manufacturing Market
5.7 ESG Ratings of Leading Companies

6 VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine Contract Manufacturing Sales Market Share by Type (2020-2025)
6.3 Global Vaccine Contract Manufacturing Market Size by Type (2020-2025)
6.4 Global Vaccine Contract Manufacturing Price by Type (2020-2025)

7 VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine Contract Manufacturing Market Sales by Application (2020-2025)
7.3 Global Vaccine Contract Manufacturing Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccine Contract Manufacturing Sales Growth Rate by Application (2020-2025)

8 VACCINE CONTRACT MANUFACTURING MARKET SALES BY REGION

8.1 Global Vaccine Contract Manufacturing Sales by Region
  8.1.1 Global Vaccine Contract Manufacturing Sales by Region
  8.1.2 Global Vaccine Contract Manufacturing Sales Market Share by Region
8.2 Global Vaccine Contract Manufacturing Market Size by Region
  8.2.1 Global Vaccine Contract Manufacturing Market Size by Region
  8.2.2 Global Vaccine Contract Manufacturing Market Size by Region
8.3 North America
  8.3.1 North America Vaccine Contract Manufacturing Sales by Country
  8.3.2 North America Vaccine Contract Manufacturing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Vaccine Contract Manufacturing Sales by Country
  8.4.2 Europe Vaccine Contract Manufacturing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Vaccine Contract Manufacturing Sales by Region
  8.5.2 Asia Pacific Vaccine Contract Manufacturing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Vaccine Contract Manufacturing Sales by Country
  8.6.2 South America Vaccine Contract Manufacturing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Vaccine Contract Manufacturing Sales by Region
  8.7.2 Middle East and Africa Vaccine Contract Manufacturing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 VACCINE CONTRACT MANUFACTURING MARKET PRODUCTION BY REGION

9.1 Global Production of Vaccine Contract Manufacturing by Region(2020-2025)
9.2 Global Vaccine Contract Manufacturing Revenue Market Share by Region (2020-2025)
9.3 Global Vaccine Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccine Contract Manufacturing Production
  9.4.1 North America Vaccine Contract Manufacturing Production Growth Rate (2020-2025)
  9.4.2 North America Vaccine Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccine Contract Manufacturing Production
  9.5.1 Europe Vaccine Contract Manufacturing Production Growth Rate (2020-2025)
  9.5.2 Europe Vaccine Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccine Contract Manufacturing Production (2020-2025)
  9.6.1 Japan Vaccine Contract Manufacturing Production Growth Rate (2020-2025)
  9.6.2 Japan Vaccine Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccine Contract Manufacturing Production (2020-2025)
  9.7.1 China Vaccine Contract Manufacturing Production Growth Rate (2020-2025)
  9.7.2 China Vaccine Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Diosynth
  10.1.1 Diosynth Basic Information
  10.1.2 Diosynth Vaccine Contract Manufacturing Product Overview
  10.1.3 Diosynth Vaccine Contract Manufacturing Product Market Performance
  10.1.4 Diosynth Business Overview
  10.1.5 Diosynth SWOT Analysis
  10.1.6 Diosynth Recent Developments
10.2 Emergent BioSolutions
  10.2.1 Emergent BioSolutions Basic Information
  10.2.2 Emergent BioSolutions Vaccine Contract Manufacturing Product Overview
  10.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Product Market Performance
  10.2.4 Emergent BioSolutions Business Overview
  10.2.5 Emergent BioSolutions SWOT Analysis
  10.2.6 Emergent BioSolutions Recent Developments
10.3 Goodwin Biotechnology
  10.3.1 Goodwin Biotechnology Basic Information
  10.3.2 Goodwin Biotechnology Vaccine Contract Manufacturing Product Overview
  10.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Product Market Performance
  10.3.4 Goodwin Biotechnology Business Overview
  10.3.5 Goodwin Biotechnology SWOT Analysis
  10.3.6 Goodwin Biotechnology Recent Developments
10.4 Bavarian Nordic
  10.4.1 Bavarian Nordic Basic Information
  10.4.2 Bavarian Nordic Vaccine Contract Manufacturing Product Overview
  10.4.3 Bavarian Nordic Vaccine Contract Manufacturing Product Market Performance
  10.4.4 Bavarian Nordic Business Overview
  10.4.5 Bavarian Nordic Recent Developments
10.5 Soligenix Inc
  10.5.1 Soligenix Inc Basic Information
  10.5.2 Soligenix Inc Vaccine Contract Manufacturing Product Overview
  10.5.3 Soligenix Inc Vaccine Contract Manufacturing Product Market Performance
  10.5.4 Soligenix Inc Business Overview
  10.5.5 Soligenix Inc Recent Developments
10.6 Catalent Biologics
  10.6.1 Catalent Biologics Basic Information
  10.6.2 Catalent Biologics Vaccine Contract Manufacturing Product Overview
  10.6.3 Catalent Biologics Vaccine Contract Manufacturing Product Market Performance
  10.6.4 Catalent Biologics Business Overview
  10.6.5 Catalent Biologics Recent Developments

11 VACCINE CONTRACT MANUFACTURING MARKET FORECAST BY REGION

11.1 Global Vaccine Contract Manufacturing Market Size Forecast
11.2 Global Vaccine Contract Manufacturing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Vaccine Contract Manufacturing Market Size Forecast by Country
  11.2.3 Asia Pacific Vaccine Contract Manufacturing Market Size Forecast by Region
  11.2.4 South America Vaccine Contract Manufacturing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Vaccine Contract Manufacturing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Vaccine Contract Manufacturing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Vaccine Contract Manufacturing by Type (2026-2035)
  12.1.2 Global Vaccine Contract Manufacturing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Vaccine Contract Manufacturing by Type (2026-2035)
12.2 Global Vaccine Contract Manufacturing Market Forecast by Application (2026-2035)
  12.2.1 Global Vaccine Contract Manufacturing Sales (K Units) Forecast by Application
  12.2.2 Global Vaccine Contract Manufacturing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Vaccine Contract Manufacturing Market Size by Type (M USD)
Table 4. Global Vaccine Contract Manufacturing Market Size by Application
Table 5. Vaccine Contract Manufacturing Market Size Comparison by Region (M USD)
Table 6. Global Vaccine Contract Manufacturing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Vaccine Contract Manufacturing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Vaccine Contract Manufacturing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Vaccine Contract Manufacturing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2025)
Table 11. Global Market Vaccine Contract Manufacturing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Vaccine Contract Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine Contract Manufacturing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Vaccine Contract Manufacturing Sales by Type (K Units)
Table 27. Global Vaccine Contract Manufacturing Market Size by Type (M USD)
Table 28. Global Vaccine Contract Manufacturing Sales (K Units) by Type (2020-2025)
Table 29. Global Vaccine Contract Manufacturing Sales Market Share by Type (2020-2025)
Table 30. Global Vaccine Contract Manufacturing Market Size (M USD) by Type (2020-2025)
Table 31. Global Vaccine Contract Manufacturing Market Share by Type (2020-2025)
Table 32. Global Vaccine Contract Manufacturing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Vaccine Contract Manufacturing Sales (K Units) by Application
Table 34. Global Vaccine Contract Manufacturing Market Size by Application
Table 35. Global Vaccine Contract Manufacturing Sales by Application (2020-2025) & (K Units)
Table 36. Global Vaccine Contract Manufacturing Sales Market Share by Application (2020-2025)
Table 37. Global Vaccine Contract Manufacturing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Vaccine Contract Manufacturing Market Share by Application (2020-2025)
Table 39. Global Vaccine Contract Manufacturing Sales Growth Rate by Application (2020-2025)
Table 40. Global Vaccine Contract Manufacturing Sales by Region (2020-2025) & (K Units)
Table 41. Global Vaccine Contract Manufacturing Sales Market Share by Region (2020-2025)
Table 42. Global Vaccine Contract Manufacturing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Vaccine Contract Manufacturing Market Size by Region (2020-2025)
Table 44. North America Vaccine Contract Manufacturing Sales by Country (2020-2025) & (K Units)
Table 45. North America Vaccine Contract Manufacturing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Vaccine Contract Manufacturing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Vaccine Contract Manufacturing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Vaccine Contract Manufacturing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Vaccine Contract Manufacturing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Vaccine Contract Manufacturing Sales by Country (2020-2025) & (K Units)
Table 51. South America Vaccine Contract Manufacturing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Vaccine Contract Manufacturing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Vaccine Contract Manufacturing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Vaccine Contract Manufacturing Production (K Units) by Region(2020-2025)
Table 55. Global Vaccine Contract Manufacturing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Vaccine Contract Manufacturing Revenue Market Share by Region (2020-2025)
Table 57. Global Vaccine Contract Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Vaccine Contract Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Vaccine Contract Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Vaccine Contract Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Vaccine Contract Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Diosynth Basic Information
Table 63. Diosynth Vaccine Contract Manufacturing Product Overview
Table 64. Diosynth Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Diosynth Business Overview
Table 66. Diosynth SWOT Analysis
Table 67. Diosynth Recent Developments
Table 68. Emergent BioSolutions Basic Information
Table 69. Emergent BioSolutions Vaccine Contract Manufacturing Product Overview
Table 70. Emergent BioSolutions Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Emergent BioSolutions Business Overview
Table 72. Emergent BioSolutions SWOT Analysis
Table 73. Emergent BioSolutions Recent Developments
Table 74. Goodwin Biotechnology Basic Information
Table 75. Goodwin Biotechnology Vaccine Contract Manufacturing Product Overview
Table 76. Goodwin Biotechnology Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Goodwin Biotechnology Business Overview
Table 78. Goodwin Biotechnology SWOT Analysis
Table 79. Goodwin Biotechnology Recent Developments
Table 80. Bavarian Nordic Basic Information
Table 81. Bavarian Nordic Vaccine Contract Manufacturing Product Overview
Table 82. Bavarian Nordic Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bavarian Nordic Business Overview
Table 84. Bavarian Nordic Recent Developments
Table 85. Soligenix Inc Basic Information
Table 86. Soligenix Inc Vaccine Contract Manufacturing Product Overview
Table 87. Soligenix Inc Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Soligenix Inc Business Overview
Table 89. Soligenix Inc Recent Developments
Table 90. Catalent Biologics Basic Information
Table 91. Catalent Biologics Vaccine Contract Manufacturing Product Overview
Table 92. Catalent Biologics Vaccine Contract Manufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Catalent Biologics Business Overview
Table 94. Catalent Biologics Recent Developments
Table 95. Global Vaccine Contract Manufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 96. Global Vaccine Contract Manufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Vaccine Contract Manufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 98. North America Vaccine Contract Manufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Vaccine Contract Manufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 100. Europe Vaccine Contract Manufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Vaccine Contract Manufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 102. Asia Pacific Vaccine Contract Manufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Vaccine Contract Manufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 104. South America Vaccine Contract Manufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Vaccine Contract Manufacturing Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Vaccine Contract Manufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Vaccine Contract Manufacturing Sales Forecast by Type (2026-2035) & (K Units)
Table 108. Global Vaccine Contract Manufacturing Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Vaccine Contract Manufacturing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 110. Global Vaccine Contract Manufacturing Sales (K Units) Forecast by Application (2026-2035)
Table 111. Global Vaccine Contract Manufacturing Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Vaccine Contract Manufacturing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine Contract Manufacturing Market Size (M USD), 2025-2035
Figure 5. Global Vaccine Contract Manufacturing Market Size (M USD) (2020-2035)
Figure 6. Global Vaccine Contract Manufacturing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine Contract Manufacturing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccine Contract Manufacturing Product Life Cycle
Figure 13. Vaccine Contract Manufacturing Sales Share by Manufacturers in 2025
Figure 14. Global Vaccine Contract Manufacturing Revenue Share by Manufacturers in 2025
Figure 15. Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Vaccine Contract Manufacturing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccine Contract Manufacturing Revenue in 2025
Figure 18. Industry Chain Map of Vaccine Contract Manufacturing
Figure 19. Global Vaccine Contract Manufacturing Market PEST Analysis
Figure 20. Global Vaccine Contract Manufacturing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccine Contract Manufacturing Market Share by Type
Figure 27. Sales Market Share of Vaccine Contract Manufacturing by Type (2020-2025)
Figure 28. Sales Market Share of Vaccine Contract Manufacturing by Type in 2025
Figure 29. Market Share of Vaccine Contract Manufacturing by Type (2020-2025)
Figure 30. Market Share of Vaccine Contract Manufacturing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccine Contract Manufacturing Market Share by Application
Figure 33. Global Vaccine Contract Manufacturing Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccine Contract Manufacturing Sales Market Share by Application in 2025
Figure 35. Global Vaccine Contract Manufacturing Market Share by Application (2020-2025)
Figure 36. Global Vaccine Contract Manufacturing Market Share by Application in 2025
Figure 37. Global Vaccine Contract Manufacturing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccine Contract Manufacturing Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccine Contract Manufacturing Market Size by Region (2020-2025)
Figure 40. North America Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Vaccine Contract Manufacturing Sales Market Share by Country in 2024
Figure 43. North America Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccine Contract Manufacturing Market Size by Country in 2024
Figure 45. U.S. Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccine Contract Manufacturing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Vaccine Contract Manufacturing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccine Contract Manufacturing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccine Contract Manufacturing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Vaccine Contract Manufacturing Sales Market Share by Country in 2024
Figure 53. Europe Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccine Contract Manufacturing Market Size by Country in 2024
Figure 55. Germany Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccine Contract Manufacturing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Vaccine Contract Manufacturing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccine Contract Manufacturing Market Size by Region in 2024
Figure 68. China Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccine Contract Manufacturing Sales and Growth Rate (K Units)
Figure 79. South America Vaccine Contract Manufacturing Sales Market Share by Country in 2024
Figure 80. South America Vaccine Contract Manufacturing Market Size and Growth Rate (M USD)
Figure 81. South America Vaccine Contract Manufacturing Market Size by Country in 2024
Figure 82. Brazil Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccine Contract Manufacturing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Vaccine Contract Manufacturing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccine Contract Manufacturing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccine Contract Manufacturing Market Size by Region in 2024
Figure 92. Saudi Arabia Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccine Contract Manufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Vaccine Contract Manufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccine Contract Manufacturing Production Market Share by Region (2020-2025)
Figure 103. North America Vaccine Contract Manufacturing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Vaccine Contract Manufacturing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Vaccine Contract Manufacturing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Vaccine Contract Manufacturing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Vaccine Contract Manufacturing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Vaccine Contract Manufacturing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Vaccine Contract Manufacturing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Vaccine Contract Manufacturing Market Share Forecast by Type (2026-2035)
Figure 111. Global Vaccine Contract Manufacturing Sales Forecast by Application (2026-2035)
Figure 112. Global Vaccine Contract Manufacturing Market Share Forecast by Application (2026-2035)


More Publications